Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Moredun announces novel louping ill project
Louping ill is a serous tick-borne virus of sheep and red grouse.
Scientists to develop new vaccine with the Game and Wildlife Conservation Trust

The Moredun Research Institute and the Game and Wildlife Conservation Trust (GWCT) have joined forces in a bid to combat the growing issue of looping ill, a serious tick-borne virus of sheep and red grouse.

In the 1930s, Moredun developed an effective louping ill vaccine, but it was recently withdrawn from manufacture. The vaccine had been hailed as a game changer for sheep farmers and grouse moor managers alike.

Recently, tick populations have been growing and been expanding their reach into areas where they previously had not been an issue. With this came a rise in tick-borne illnesses and, in the absence of a louping ill vaccine, serious losses in both sheep and red grouse.

“We have had many reports from our hill farming members that they have been losing sheep, mainly ewe hoggs to louping ill, some losing up to 25 per cent of their replacement females which is a serious loss,” explained Dr Beth Wells from the Moredun Research Institute.

“We already have successful partnerships with GWCT and are delighted they have joined us in a new project to work towards a novel vaccine for louping ill control.”

Scientists have identified potential candidates for a new generation louping ill vaccine. These will require further research to ensure they cause an immune response in sheep and protect animals against louping ill.

“This important work will be vital in the fight against LIV, and GWCT is pleased to have been able to help in raising the funds for the Moredun’s work as a separate initiative to our core fundraising activity,” said Dr Adam Smith of the GWCT.

Moredun chair Ian Duncan Miller added: “This research illustrates the benefits of working in partnership and we are very pleased to be working alongside GWCT with this project, which is of extreme importance to both of our industries. This project takes Moredun back to its roots in tackling a really serious disease in the hills and uplands.”

Researchers said the project is due to start later this year and, if successful, will be pushed towards commercialisation ‘as soon a possible’.

Become a member or log in to add this story to your CPD history

Animal Medicines Amnesty returns this November

News Story 1
 Veterinary practices are being urged to help owners safely dispose of any unused and expired pet medicines - not just antibiotics - during November's Animal Medicines Amnesty.

Organised by the Responsible Use of Medicines Alliance Companion Animal and Equine (RUMA CA&E), the initative is supported by a range of cross-sector organisations.

Practices are encouraged to use the campaign to engage the whole practice team and raise awareness of the safe disposal of medicines with clients. Learn how your practice can get involved at rumacae.org.uk 

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.